Articles of note for people dealing with pituitary disease and related conditions.
The latest from pharmaceutical companies and healthcare organizations
Brief, insightful commentary from Dr. Lewis Blevins on issues of relevance to pituitary disease.
Watch Pituitary 101: how your pituitary works and how we test its function
This comprehensive educational program delves deep into the gland’s anatomy and physiology, offering detailed explanations of laboratory testing and expert guidance on interpreting those results.
A new book on Hypopituitarism coming in early 2025: listen to an excerpt
More books are on the way. A new book on Hypopituitarism is scheduled to be published in January 2025, and a book on prolactinomas and Pituitary Tumors is slated for late winter and spring 2025, respectively.
Worth noting:
From Crinetics Pharmaceuticals – FDA accepts Crinetics new drug Paltusotine’s application for adults with acromegaly . Read more
Camurus announces final results for the once-monthly octreotide subcutaneous treatment option for acromegaly. Read more
News from Recordati on osilodrostat for endogenous Cushing’s – More details here
Corcept Therapeutics reports significant results in Cushing’s drug trial. Read more
New support site from Chiesi; Rethink acromegaly
Pfizer announces Together with Acromegaly patient support site and Together for Rare: Understanding your insurance options video.
Chiesi relaunches a patient-facing website for Mycapssa.
Content for physicians and healthcare professionals.
Join a drug trial. Find out how. Here’s a partial list of studies.
Latest trends and a roundup of health and wellness news
The Podcast
Knowledge and information are critical tools to affect early diagnosis in pituitary disease. Join Dr. Lewis Blevins and Jorge D Faccinetti cofounders, as they navigate the wonders and complexities of pituitary conditions.
Live Talk on Demand
Apple Podcasts
Spotify
Amazon Music
Google PodcastsEvents
